Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03114293
Other study ID # inims-pia
Secondary ID
Status Active, not recruiting
Phase N/A
First received March 31, 2017
Last updated May 2, 2017
Start date April 1, 2016
Est. completion date May 30, 2017

Study information

Verified date May 2017
Source Universitätsklinikum Hamburg-Eppendorf
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Due to their ubiquitary distribution, smartphones might serve as an easy way/ possibility to use feedback mechanism in an app-based intervention program to increase physical activity in Multiple Sclerosis (MS) patients. Internet based cognitive-behavioral interventions have been explored as effective in the last years. In addition, smartphone-based mobility assessment and intervention might be a promising approach in other MS types and for real-life mobility assessment in observational and interventional trials. The aim is to investigate the impact of a smartphone based information and feedback program on physical activity in a 3 months, randomised waiting-group controlled trial of 40 progressive MS patients.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date May 30, 2017
Est. primary completion date May 30, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- progressive MS

Exclusion Criteria:

- other major health disorder

- EDSS above 6

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Smartphone App
The app includes an EBPI and physical activity feedback

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universitätsklinikum Hamburg-Eppendorf

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of responders Rate of responders as defined by a 20% increase of steps or 20% increase in physical activity as measured with the actigraph 3 Months
Secondary Physical activity: total activity Physical activity and real-life mobility: 1-week accelerometry (actigraph) 3 Months
Secondary Physical activity: distance per day Physical activity and real-life mobility: 1-week accelerometry (actigraph) 3 Months
Secondary Physical activity: number of steps per day Physical activity and real-life mobility: 1-week accelerometry (actigraph) 3 Months
Secondary Questionnaires on quality of life (QoL, HAQUAMS) Disease specific quality of life questionnaire 3 Months
Secondary Questionnaires on activities of daily living (ADL) Frenchay activity index 3 Months
Secondary Questionnaires on physical activity Godin Leisure time 3 Months
See also
  Status Clinical Trial Phase
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Completed NCT01188811 - Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) Phase 2/Phase 3
Recruiting NCT05562414 - Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis N/A
Completed NCT02545959 - Intrathecal Rituximab in Progressive Multiple Sclerosis Phase 2
Completed NCT01436838 - China Betaferon Adherence, Coping and Nurse Support Study N/A
Completed NCT03799718 - Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS Phase 2
Recruiting NCT00220493 - Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients Phase 1
Recruiting NCT05496881 - Exercise Effects in Multiple Sclerosis N/A
Recruiting NCT02903537 - Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) Phase 1
Temporarily not available NCT02606929 - Use of Well Known Drugs for New Destination - MS Improvement (MSNT) Phase 0
Completed NCT03424538 - The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients N/A
Completed NCT02403570 - Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
Active, not recruiting NCT04993274 - Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
Active, not recruiting NCT00411723 - Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis Phase 1
Completed NCT00241254 - Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis Phase 3
Completed NCT02632591 - Use on Human Beings of Mix of Known Drugs for New Destination - MS Treatment Phase 1
Not yet recruiting NCT05385731 - MUSCLE - Nordic Walking in MUltiple SCLErosis N/A
Recruiting NCT05359653 - Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy Phase 1/Phase 2
Completed NCT04550650 - Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients N/A